Literature DB >> 6768943

L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression.

J Mann, S Gershon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768943     DOI: 10.1016/0024-3205(80)90350-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  18 in total

1.  An analgesic effect of enkephalinase inhibition is modulated by monoamine oxidase-B and REM sleep deprivations.

Authors:  O E Ukponmwan; J Rupreht; M Dzoljic
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

Review 2.  Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease.

Authors:  John P M Finberg
Journal:  J Neural Transm (Vienna)       Date:  2018-11-01       Impact factor: 3.575

Review 3.  The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).

Authors:  I Miklya
Journal:  Mol Psychiatry       Date:  2016-08-02       Impact factor: 15.992

4.  Enhanced pressor sensitivity to oral tyramine challenge following high dose selegiline treatment.

Authors:  A Prasad; V Glover; B L Goodwin; M Sandler; M Signy; S E Smith
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  (-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain.

Authors:  J Knoll; F Yoneda; B Knoll; H Ohde; I Miklya
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  L-deprenyl plus L-phenylalanine in the treatment of depression.

Authors:  W Birkmayer; P Riederer; W Linauer; J Knoll
Journal:  J Neural Transm       Date:  1984       Impact factor: 3.575

7.  Effects of deprenyl on monoamine oxidase and neurotransmitters in the brains of MPTP-treated aging mice.

Authors:  M Gupta; H L Wiener
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

8.  Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

Review 9.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B.

Authors:  A Kalir; A Sabbagh; M B Youdim
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.